怕来不及，收盘前先喊一嗓子，晚上再来分析

tina15sun

HEB delay up to 1-2 weeks approval，只要不会生变，没有坏消息，握住就好。当然不知道什么时候会公布，未定的心总是揪着。老大有什么最新消息没有。谢谢老大辛苦与分享。
见xx老大又加码acus，什么原因使你如此笃定？老大的定心是小股友的定心丸。大谢！

任何变数，请大吼一声！THANKS！

ffpp

问老大一声，从哪里可以找到最近fda要审批的公司list？多谢了

jiaming12

老大！你怎么能把insiders buy那个帖子雪藏在德国版呢？！！！呜呜 我要是早些看到一定load些....  {:5_303

wildonion

老大！你怎么能把insiders buy那个帖子雪藏在德国版呢？！！！呜呜 我要是早些看到一定load些....  {:5_303
jiaming12 发表于 2009-5-27 22:06

SECOND this!!!

zhao

UHTX

IENTERTAINMENT NETWORK INCORPORATED (OTC: IENT)
"Up 900.00% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/IENT.php

iEntertainment Network, Inc. is a leading provider of online entertainment communities and publisher of online and retail games. "WarBirds 2009," IENT's premiere massively multiplayer flight simulation software, which plays on both PCs and MAC computers, has won numerous awards around the world for Best Online Simulation Game and attracts players from over 70 countries. iEntertainment holds an Internet Patent, Number 6,042,477, integral to the development and support of online gaming.

IENT News:

May 27 - WarBirds 2009 Gets Giant New Update

iEntertainment Network (OTC: IENT), the award-winning developer of the World Famous WarBirds TotalSims series of military MMOGs, announced that a brand new WarBirds 2009 version of the Massively Multiplayer Online Simulation has been launched with a significant product update including New Aircraft, New Flight Models, New Terrains, and many more new features.

Major updates to flight models of the WarBirds 2009 aircraft include special emphasis on Navy aircraft including all Corsairs, the Hellcat, the TBD Devastator and the SBD Dauntless and a complete revision of all flight models for WWI aircraft including the Albatross DVa, the Sopwith Camel, Fokker DR1 and DVII, Nieuport and Spads. New cockpits and new gun stations were also added to the B-25 series of bombers.

WarBirds 2009 features two Brand New Terrains (The Somme and Alsace) for the two Bonus WarBirds games: Dawn of Aces (WWI Combat Flying) and Armored Assault (WWII Tank Simulation). These updates include Player flyable Handley Page and Gotha bombers, a new Halberstadt CL II version, Zeppelin refinements, and a new German Tiger II tank.

The WarBirds 2009 simulation also now includes new modern aircraft, the UAV MQ-1 Predator and the US Air Force trainer T-6A Texan II.

WarBirds 2009 adds new and improved Training for new WarBirds players: A special "CheckOut" for more experienced players and a "CheckRide" training system, to ensure that new players can learn the simulation more quickly and survive longer in the online arenas.

WarBirds has been called one of the best combat operations game ever produced. The award-winning title allows players from around the world to enter persistent online battlefield and take control of more than 120 different aircraft and vehicles, including fighters, bombers, tanks, and Naval vessels.

UHTX

OCULUS INNOVATIVE SCIENCES INCORPORATED (NASDAQ: OCLS)
"Up 241.67% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/OCLS.php

Oculus Innovative Sciences develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, which is intended to help prevent and treat infections in chronic and acute wounds. The Microcyn Technology platform features a biocompatible, shelf-stable solution containing active oxychlorine compounds that is currently commercialized primarily in the United States, Europe, India, China and Mexico for the treatment of infected wounds. The solutions derived from this platform have demonstrated, in a variety of research and investigational studies, the ability to treat a wide range of pathogens, including antibiotic-resistant strains of bacteria (including MRSA and VRE), viruses, fungi and spores. A recent Phase II clinical trial of Microcyn Technology conducted in the United States met its primary endpoints of safety and efficacy for the treatment of mildly infected diabetic foot ulcers. The company’s headquarters are in Petaluma, California, with operations in Europe and Latin America.

OCLS News:

May 27 - Oculus Innovative Sciences Receives FDA Clearance for Microcyn Skin and Wound Gel

Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a healthcare company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Microcyn® Skin and Wound Gel as both a prescription and over-the-counter formulation. The Rx product, under the supervision of a health care professional, is intended for management of exuding wounds such as leg ulcers, pressure ulcers, diabetic ulcers and for the management of mechanically or surgically debrided wounds. This is the first hydrogel product based upon the Microcyn Technology platform and is reimbursable by both Medicare and Medicaid.

The original Microcyn-based solution, branded as Microcyn Wound Care in the United States, Microdacyn60™ in Mexico, Dermacyn™ Wound Care in Europe and China and Oxum in India, has treated over one million patients worldwide without a report of a single serious adverse effect.

“We are pleased to receive FDA clearance for this Microcyn hydrogel product,” said Hoji Alimi, founder and CEO of Oculus. “We understand the critical role that reimbursement plays in the successful commercialization of a medical product, and in that this is our first reimbursable product, we plan to aggressively market to the U.S. healthcare community. At the same time, we are taking all steps necessary to secure regulatory approvals outside North America so as to begin generating international sales through our existing distribution channels worldwide.”

Oculus, in partnership with its North American contract sales organization, Advocos, will market and sell the Microcyn® Skin and Wound Gel to the North American medical community as well as consumers beginning in June 2009.